BI 3810944 / Boehringer Ingelheim - LARVOL DELTA

A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps (clinicaltrials.gov) - P1 | N=75 | Not yet recruiting | Sponsor: Boehringer Ingelheim

First-in-human • New P1 trial • Melanoma • Oncology • Solid Tumor